Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects

Conditions

• Hepatic Impairment
• Healthy

Interventions

• DRUG: lumacaftor 200 mg q12h + ivacaftor 250 mg q12h

Sponsor

Vertex Pharmaceuticals Incorporated